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Abstract: The pancreatic beta-cell transduces the availability of nutrients into the secretion of insulin.
While this process is extensively modified by hormones and neurotransmitters, it is the availability
of nutrients, above all glucose, which sets the process of insulin synthesis and secretion in motion.
The central role of the mitochondria in this process was identified decades ago, but how changes
in mitochondrial activity are coupled to the exocytosis of insulin granules is still incompletely
understood. The identification of ATP-sensitive K+-channels provided the link between the level of
adenine nucleotides and the electrical activity of the beta cell, but the depolarization-induced Ca2+-
influx into the beta cells, although necessary for stimulated secretion, is not sufficient to generate
the secretion pattern as produced by glucose and other nutrient secretagogues. The metabolic
amplification of insulin secretion is thus the sequence of events that enables the secretory response
to a nutrient secretagogue to exceed the secretory response to a purely depolarizing stimulus and
is thus of prime importance. Since the cataplerotic export of mitochondrial metabolites is involved
in this signaling, an orienting overview on the topic of nutrient secretagogues beyond glucose is
included. Their judicious use may help to define better the nature of the signals and their mechanism
of action.
Keywords: cytosolic calcium concentration; glucose; insulin secretion; metabolic amplification;
mitochondria; nutrient secretagogues
1. The Biphasic Pattern of Insulin Secretion Can Be Produced in Different
Experimental Settings
The endocrine pancreas responds to an increase in glucose in the bloodstream with a
biphasic pattern of insulin release, represented by a short (5–10 min) first phase, followed by
a long, sustained second phase release. This unique feature is best shown in response to a
‘square wave’ glucose stimulus, which is produced in vivo by the hyperglycaemic clamp [1].
It is obvious that such a stimulation pattern is non-physiological, but the resulting biphasic
response is the hallmark of the healthy endocrine pancreas. In type 2 diabetes (T2D)
and animal models of this disease, it displays varying degrees of a diminished insulin
response, often described to be more prominent during the first phase but also recognizable
during the second phase [2,3]. The demonstration that metabolically healthy first-degree
relatives of T2D patients have a diminished secretory response during a hyperglycaemic
clamp [4] and that insulin-sensitive offspring of T2D patients have diminished beta-cell
function [5] suggest that beta-cell dysfunction is an independent pathogenic factor driving
the progressive impairment of glucose homeostasis in the course of T2D [6]. The low
incidence of T2D during historical periods of food shortage shows that beta-cell dysfunction
is rarely sufficient for manifestation in the absence of insulin resistance.
Originally demonstrated in vivo, the biphasic secretion pattern could also be demon-
strated in vitro, or more precisely, ex vivo, using the model of the perfused rat [7,8] or
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mouse pancreas [9] and, after the introduction of the collagenase isolation technique, with
the more reductionist model of the batch-perifused isolated islets [10,11]. Theoretically,
it is possible that the phenomenologically similar secretion pattern in vivo and ex vivo
may result from different mechanisms. In a less apodictic form, namely that the relative
contribution of the processes involved in shaping the secretion pattern may vary between
the different experimental systems, this argument is worth considering (see below). Just to
illustrate this point, the effect of incretins is certainly absent in perifused islets, which may
be responsible for their more protracted and less dynamic responses.
Today, a large part of the basic research on beta-cell function is performed using
insulin-secreting cell lines, often referred to as clonal beta cells. In addition to the initially
perceived advantage, to generate a steady supply of insulin-secreting cells with standard-
ized properties without the hazards and time consumption of collagenase digestion, the
ease of transfection has made them popular tools. Thus, cell lines are also used for the
study of metabolism-derived signals for secretion (see, e.g., [12,13]). However, it has to be
kept in mind that the much larger biosynthetic activity as a precondition for the higher
rates of mitosis represents a drain of metabolites. This is one of the reasons why quickly
proliferating cell lines, such as RINm5F, have a poor secretory response to metabolic stim-
ulation, whereas highly differentiated cell lines, such as INS-1E, have a better response
but proliferate only slowly [14,15]. Interestingly, three-dimensional aggregates of MIN6
cells, also called MIN6 pseudo-islets, show a higher secretory response to glucose than the
equivalent number of MIN6 cells in monolayer [16] and can be perifused like primary islets.
Still, the kinetics and dynamic range of secretion are inferior to the one of primary islets.
2. The Early Years: Substrate Site Hypothesis versus Receptor Site Hypothesis
Very early investigations, using a number of metabolizable and non-metabolizable car-
bohydrates, suggested that stimulated insulin secretion required the metabolic breakdown
of the glucose [17,18]. For example, glucose and mannose stimulated insulin secretion,
whereas 2-deoxyglucose, 3-O-methylglucose, and galactose did not. However, it was diffi-
cult to verify that increases in the level of potential signal-conveying metabolites occurred
during the initial phase of stimulated secretion; thus, the alternative view evolved, namely
that glucose stimulates insulin secretion by binding to a plasma membrane receptor [19].
The demonstration that the NAD(P)H-autofluorescence of perifused islets increased, co-
inciding with the onset of stimulated secretion, suggested that the level of mitochondrial
reducing equivalents increased during the onset of secretion [20] and supported the sub-
strate site hypothesis.
Perhaps, some of the earlier controversies were caused by the existence of sweet taste
receptors at the beta-cell plasma membrane, the activation of which may lead to a leftward
shift of the threshold of glucose stimulation [21]. The receptor concept survived in modified
form when the prominent role of the glucokinase, the first glucose-metabolizing enzyme
in the beta cells, to regulate the velocity of glucose breakdown was recognized [22–24].
Actually, the biochemical or pharmacological enhancement of the glucokinase activity
proved to have insulinotropic consequences [25,26]. Nevertheless, it remained unclear for
some time whether proximal events of glucose metabolism could directly affect insulin
secretion [27] or whether the complete degradation of the glucose carbon to CO2 and
increased oxidative phosphorylation was necessary for signal generation and not just a
complicating by-product of glucose metabolism.
3. What Are Nutrient Secretagogues?
The metabolization of glucose as a precondition for its insulinotropic effect has be-
come textbook knowledge. In consequence, not only the earlier disputes but also, the
earlier experimental approaches to characterize the relation between the nutrient and
the insulinotropic properties are becoming less widely known. In view of the still unre-
solved issues, they may not only be of historical interest. The insulinotropic property of
non-carbohydrates belongs to this chapter.
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In addition to the few insulinotropic carbohydrates, some amino acids and monocar-
boxylic keto acids are insulinotropic. However, the concentrations needed to elicit insulin
secretion are beyond their physiological ranges in the serum of humans and mice. So, they
cannot be named physiological stimulators, even if the mechanisms they activate within the
beta cell are physiological in the sense that even prolonged stimulation is not detrimental
for beta-cell function and viability. This sets them apart from more robust stimuli, such
as depolarization, by high extracellular potassium concentration (see below). The feature
which made (and still makes) amino acids and keto acids interesting as heuristics tools is
that their catabolism and the one of glucose only meet in the mitochondrial matrix, thus
reducing the number of possible mechanisms involved in stimulus-secretion coupling.
The amino acid which is able to elicit insulin secretion in the absence of glucose
is leucine. Its insulinotropic efficacy is strongly enhanced by combination with glu-
tamine, which by itself is ineffective [28,29]. The series of keto acids are of interest since
their catabolism shows differences, as shown by their insulinotropic efficacy. Alpha-
ketoisocaproic acid (KIC), alpha-ketocaproate, alpha-ketovalerate, and alpha-keto-beta-
methylvalerate are all insulinotropic [30]. KIC has the strongest insulinotropic effect, on a
par with glucose, albeit with different kinetics. Alpha-ketoisovalerianic acid (KIV) is not
insulinotropic but can enhance the efficacy of other nutrient secretagogues. Actually, the
term nutrient secretagogue for such compounds is preferable over “fuels” since they do
not only support ATP generation but like glucose, support the biosynthesis of insulin, as
has been shown for the combination of leucine and glutamine [31].
All of the above insulinotropic compounds support the generation of reducing equiv-
alents by the Krebs cycle in the mitochondrial matrix, either by being catabolized them-
selves or by activating the catabolism of endogenous nutrients. Like leucine, BCH (2-
amino-bicyclo [2.2.1]heptane-2-carboxylic acid), a non-metabolizable structural analogue
of leucine, activates glutamate dehydrogenase and provides the citric acid cycle with
alpha-ketoglutarate [32]. Similarly, beta-phenylpyruvate is not metabolizable but serves
as transamination partners for glutamate and glutamine [33]. In the course of phenylke-
tonuria, an inborn error of metabolism, phenylpyruvate can reach concentrations that
inappropriately stimulate insulin secretion and generate hypoglycaemia [34]. The role
as a transamination partner is also relevant for KIC, which is itself metabolized, yielding
acetyl-CoA, but also transaminates glutamate and thus provides the Krebs cycle with
alpha-ketoglutarate [30]. Inhibition of transamination by aminooxyacetate abolishes the
insulinotropic effect of KIC [35].
However, it has to be emphasized that in contrast to glucose, not all of the keto
acids are pure nutrient secretagogues. For example, KIC and beta-phenylpyruvate were
found to directly inhibit the ATP-sensitive K+ channel (KATP channel) [36,37] in addition
to inhibiting the channel by the increased ATP/ADP ratio [38,39]. This has to be kept in
mind when interpreting secretory responses to keto acid stimulation. In this context, it
should be mentioned that distinct from other amino acids, the insulinotropic property of
arginine is not caused by metabolism but is exclusively due to the depolarization caused
by its electrogenic uptake into the beta cells [40].
4. Which Features of the Mitochondrial Metabolism Are Typical for Beta Cells?
The insulinotropic property of the above amino- and keto-acids play a major role
in defining the mitochondria as the central hub of the stimulation of insulin secretion
by nutrients (see Figure 1). Several lines of evidence contributed to this progress. First,
the demonstration that not only glucose but nutrient secretagogues in general increase
NAD(P)H-fluorescence and at the same time decrease FAD-fluorescence [41–43], which
points to the mitochondrial matrix. Second, KIC, like glucose and a number of other
nutrient secretagogues, increases oxygen consumption supporting a role for oxidative
phosphorylation [44–46]. By combining oxygen consumption measurements of perifused
islets with secretion measurements, an interesting difference in the kinetics was observed,
in that the increase in KIC-stimulated secretion closely parallels the increase in the oxygen
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consumption rate (OCR), whereas glucose generates a faster increase in the OCR, which
then turns into a slowly ascending plateau [47].
Figure 1. Both glucose and KIC exert an anaplerotic effect on the citric acid cycle in beta cells.
Glucose-derived pyruvate is either metabolized by pyruvate dehydrogenase (PDH) to acetyl-CoA
or by pyruvate carboxylase (PC) to oxaloacetate. KIC can be degraded, which yields acetyl-CoA.
It can also be transaminated with glutamate, which yields alpha-ketoglutarate and leucine. This
reaction is essential for the insulinotropic effect since inhibition of transamination by AOA inhibits
KIC-induced insulin secretion. The carbon which is fed into the citric acid cycle is derived from
glutamate, which, in turn, is generated from endogenous glutamine. The red color marks reactions
which support oxidative phosphorylation, the green color marks metabolites and reactions with
potential relevance for glucose-dependent amplification. Abbreviations: AOA = aminooxyacetate,
KIC = alpha-ketoisocaproic acid, MAG = monoacylglycerol, PL = phospholipids.
It is interesting that islet cells in situ live in a higher oxygen tension than the sur-
rounding exocrine tissue [48], even though mitochondria in beta cells make up only 4%
of the intracellular volume, much less than, e.g., in hepatocytes [49]. The higher oxygen
tension is likely a consequence of dense vascularization of the islet [50,51]. It is known
that three critical dehydrogenases of the Krebs cycle can be activated by increased Ca2+
levels [52]. Interestingly, the increase in oxygen consumption, which results from this
activation, occurs only when Ca2+ is provided by influx via L-type Ca2+ channels, not by
release from intracellular stores [53].
The role of mitochondrial metabolism for glucose-derived signal generation is em-
phasized by the fact that the fraction of glucose carbon that is oxidized increases with
accelerated glycolysis, even though it is already high at basal levels. Another notable
feature is that glucose utilization does not increase with decreasing oxygen levels [54]. The
latter feature is explained by the low activity of lactate dehydrogenase in beta cells [55].
Thus, to re-oxidize NADH in the cytosol and to keep the glycolysis running, reducing
equivalents have to be transported into the mitochondrial matrix via shuttling mecha-
nisms. This is enabled by a high expression level of the FAD-linked glycerol-3-phosphate
dehydrogenase [56]. The use of pyruvate in beta cell mitochondria is characterized by a
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high activity of pyruvate carboxylase, which is atypical for a cell without gluconeogenic
function [57].
Finally, the specific relevance for the beta cell of the close coupling of glucose utilization
to mitochondrial metabolism is underlined by the much looser coupling in the glucagon-
secreting alpha cells [54]. Given the central position of the mitochondria in the stimulus-
secretion coupling, it is not surprising that they are considered as essential contributors to
the pathogenesis of type 2 diabetes [58].
5. Which Observations Have Led to the Hypothesis of a Bifurcating Pathway
Emanating from the Mitochondria?
The realization that nutrient-stimulated insulin secretion is dependent on mitochon-
drial activation, or more precisely, the increased oxidative phosphorylation, led to the
hypothesis that ATP or perhaps the ATP/ADP-ratio might convey the signal to the electri-
cal activity which had been observed in beta cells [59,60]. Measurements of radioactivity
from perifused islets loaded with rubidium (86Rb) identified a decrease in the potassium
conductance as the likely initiating event of electrical activity, which was required for the
initiation of exocytosis [61]. However, even though it could be shown that raising the glu-
cose concentration increased the ATP content in islets, it did not occur in the insulinotropic
concentration range of glucose, and measurements of the ATP/ADP ratio yielded incon-
clusive results [62,63]. Only when the high background by the ATP content in the insulin
granules was diminished by partial degranulation could a convincing correlation between
the ATP/ADP ratio and insulin secretion be demonstrated [64].
The missing link between changes in the ATP/ADP ratio and the electrical activity
proved to be the KATP channel, the functional identification of which was a fruit of the
newly developed patch clamp technique [65,66]. It took several years to clarify its molecular
composition, which consists of an inwardly rectifying K+ channel (Kir 6.2 = KCNJ11) as the
pore-forming unit and a member of the ATP cassette-binding family (SUR1 = ABCC8) as
the regulatory subunit [67]. While ATP4- closes the channel by interaction with the channel
pore, Mg-ADP binding to the regulatory subunit (also termed sulfonylurea receptor) has
an opening effect on the channel and modifies sulfonylurea potency [68,69]. Even though
additional metabolism-derived signals, such as H2O2 or acyl-CoA, may contribute to the
regulation of KATP channels [70,71], the ATP/ADP ratio as determined in intact islets can
be considered as a sufficient measure of the signal by which the beta cell mitochondria
initiate the electrical activity of the plasma membrane [72].
After the identification of the KATP channel as the link between energy metabolism and
electrical activity of the beta cell, the view prevailed that the depolarization induced Ca2+
influx caused by the closure of the channel would constitute the final common pathway
of insulin secretion. This view was regarded as the consensus theory of glucose-induced
insulin secretion. A test of this theory was to close the KATP channel pharmacologically
and then raise glucose from a basal to a stimulatory level. If Ca2+ influx by KATP channel
closure was the only regulator of secretion, no further increase in secretion was to be
expected. However, glucose caused an increase in secretion beyond the level established
by the maximally effective concentration of sulfonylurea [73]. The consensus theory was
further challenged by another experimental approach, where KATP channels were opened
by diazoxide to prohibit any effect of the energy metabolism on the membrane potential.
Depolarization was induced by a high extracellular potassium concentration. Because of
the large potassium conductance under this condition, the membrane potential closely
follows the Nernst potential. Again, raising glucose to a stimulatory level increased the
secretion of isolated islets beyond the level established by depolarization alone [74].
The latter approach has become the experimental standard, in part because of sus-
pected insulinotropic effects of sulfonylureas in addition to the closure of plasma membrane
KATP channels [75,76]. However, interference by intracellular sites of action also limits
the value of diazoxide as a pharmacological tool since it was shown to exert direct effects
on beta-cell mitochondria [77]. An argument in favor of pharmacologically blocking the
KATP channels is that the depolarization thus produced corresponds to the depolarization
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strength and pattern of nutrient stimulation, whereas depolarization by high potassium
can be much stronger, depending on the actual concentration, and lacks the typical pattern
of action potential spiking [78,79].
Initially often named “KATP channel-independent pathway” [80], the name “ampli-
fying pathway”, as suggested by Henquin [81], has become widely accepted. This choice
of name was based on the evidence that insulin secretion is not increased if the plasma
membrane is not depolarized, which under physiological conditions requires the closure
of the KATP channels. For this reason, the pathway is not “independent” in the proper
sense. The pathway leading to the KATP channel closure and Ca2+ influx, in contrast,
was termed “triggering pathway” [81]. Another nomenclature tries to avoid a functional
definition by simply naming the stimulus-secretion coupling via KATP channel closure the
“canonical pathway” and leaving the role of those signals undefined, which affect secretion
without causing changes in the electrical activity [82]. What is important, though, is not to
confuse the metabolic amplification, an inherent property of nutrient secretagogues, with
a receptor-mediated enhancement of secretion by neurotransmitters or hormones, such
as GLP-1.
6. Models of the Biphasic Kinetics of Secretion
A certain weakness in the definition of the amplifying pathway is that it relies on
the use of pharmacological agents prior to the nutrient stimulation. This, by necessity,
influences the secretion kinetics of the nutrient. So, to discuss whether the metabolic
amplification primarily affects early or late periods of the biphasic secretion pattern, we
have to briefly touch on the topic of which mechanisms underlie the biphasic kinetics of
secretion. In principle, two different points of view can be distinguished: one considers
the limited number of secretion-ready granules as the main responsible factor, whereas the
other considers the evolving pattern of metabolism-derived signals as the underlying cause.
The more popular hypothesis proposes that the biphasic secretion pattern results
from the existence of two different pools of granules. Its origins can be traced back to
the two-compartment model of secretion, proposing that insulin is contained in a stable
compartment and in a much smaller compartment that is labile to stimulation [83]. Based
on the combination of ultrastructural and electrophysiological data, the correlate of the
latter compartment was suggested to be a limited number of secretion-ready granules that
are firmly attached to the plasma membrane (“docked”) and fully prepared (“primed”)
for fusion [84–86]. The high fusion rate produced by depolarization-induced Ca2+ influx
depletes this pool of secretion-ready granules causing the transient decrease in the rate of
insulin secretion, observed after 10–15 min of continuous stimulation (somewhat longer
than in vivo). The progressively faster replenishment of this pool by metabolism-dependent
recruitment of a distant reserve pool causes the subsequent recovery in the insulin release
rate, taking shape as the second phase [87,88]. Since the accelerated rate of replenishment
now matches the rate of exocytosis, the secretion rate of the second phase can be maintained
for several hours until a general desensitization towards stimulation sets in, which reduces
the secretion rate to about one-third [89].
The alternative view can be named the metabolic control hypothesis. This hypothesis
proposes that the glucose metabolism in the beta cell generates stimulatory as well as
inhibitory signals [90,91]. The initial stimulatory effect is followed by a more slowly
evolving inhibitory signal which reduces the secretion rate. This process, which leads to
the nadir of the secretion rate, was named time-dependent inhibition. The hypothetical
inhibitory signal is then succeeded or overruled by a third signal evolving from the glucose
metabolism. This even more retarded reaction was named time-dependent potentiation.
The time-dependent inhibition and potentiation do not only differ in their kinetics but also
their dependency on the glucose concentration [92]. The main obstacle for this hypothesis
to gain a wider acceptance is that no clear mechanism for the inhibitory signal could
be demonstrated.
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On the other hand, the hypothesis of the time-dependent potentiation bears a clear
resemblance to the phenomenon of metabolic amplification. A comparison of the storage-
and the signal-limited model of insulin secretion gave slightly better fits for the simulation
of the signal-limited model [93]. Further progress in characterizing the fate of the insulin
granules may eventually show that both hypotheses are not mutually exclusive but rather
that the earlier model (limited storage) is related to the latter.
In this context, it is worth pointing out that a fully developed first phase with a tran-
sient decrease in the secretion rate requires the “non-physiological” square-wave stimulus
(Figure 2). A ramp-like stimulation generates a continuously ascending rate of secretion,
where the initial phase is only different from the following phase by a more steeply ascend-
ing rate of secretion [94]. In perifused islets, such a pattern also results when a maximally
effective glucose stimulus is applied after a period of nutrient deprivation [47,95]. This
suggests that the velocity with which metabolites are generated may not only determine
the initial increase in the secretion rate but also the extent of the transient decrease.
Figure 2. The kinetics of nutrient-induced insulin secretion are strongly dependent on the velocity of
nutrient increase. The only difference between the experimental conditions of the secretory responses
shown in this figure is the pump rate of the perifusion and, by consequence, the steepness of the
glucose gradient. The final concentration was reached after 5 min or 35 min, respectively.
7. Relation of the Triggering and Amplifying Pathways to the Biphasic
Secretion Kinetics
The hypothesis that the imbalance between the fusion rate of the fully prepared
granules and the velocity of granule replenishment is responsible for the first phase entails
that the relevance of the mitochondrial metabolism for secretion becomes visible during
the build-up of the second phase. Consequently, the triggering signal was often held
to be responsible for the first phase and the amplifying signal for the second phase of
glucose-stimulated secretion, see, e.g., [96].
This view was supported by observations on INS1 cells with inactivated mtDNA,
which did not secrete insulin in response to glucose but did so in response to KCl depo-
larization [97]. However, the short-term treatment of perifused islets with mitochondrial
inhibitors virtually abolished not only the insulin secretion elicited by glucose but also
the one by KCl or sulfonylureas [98]. MIN6 cells devoid of mitochondrial DNA showed
a markedly reduced secretion in response to the sulfonylurea, glibenclamide [99]. So,
the extent to which the triggering signal alone elicits secretion is less well defined than
often realized. In this context, it is worth mentioning that Ca2+ influx does not simply
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constitute the signal for granule fusion but that it may affect granule transport and thus
the availability of fusion-ready granules. In fact, the biphasic increase in the cytosolic
Ca2+ concentration, often seen in intact islets [100,101], suggests a role for the Ca2+ signal
beyond triggering.
As mentioned above, potassium depolarization has no upper limit within the physio-
logical working range of the beta cell, in contrast to KATP channel closure. The closure of
the KATP channels results in a plateau depolarization of about 20 mV by a still ill-defined
inward leak current. The superimposed action potentials result from the phasic influx of
Ca2+ via L-type channels, as can be seen by the use of blockers of these channels [102]. So,
for the experimental triggering signal to mimic the consequence of KATP channel closure
by nutrient stimulation, a depolarization by about 20 mV has to be produced to open
voltage-dependent Ca2+ channels. This is the depolarizing strength of 15 mM KCl, which
only elicits a small transient increase in secretion far below the typical range of the first
phase [102]. Of note, the presence of 15 mM KCl is not without effect. It enhances the
secretion elicited by glucose and by sulfonylureas [102,103].
These observations suggest that a strong depolarization (e.g., by 40 mM KCl and more)
can produce a first phase-like monophasic secretion, but that the weaker depolarization
produced by nutrient stimulation generates the first phase because the metabolic amplifying
is already effective. This conclusion concurs with the one drawn from observations on
the changing relation between first and second phase secretion in dependence on the
prestimulatory conditions [104]. In short, metabolic amplification is likely effective from
the beginning of nutrient-stimulated secretion.
Finally, it has to be mentioned that the live-cell imaging of fluorescently labelled
granules by TIRF microscopy have led to a much more detailed view on the insulin
granules and the events preceding the fusion process, see, e.g., [105–107]. However, these
data have not yet had a major impact on the hypothesis of triggering and amplifying
pathways. Certainly, the quantitative description of granule genesis, transport, and fusion
under triggering and amplifying conditions will be of major help to understand how the
amplifying signals enhance the secretion rate.
8. Cataplerosis and Putative Amplification Signals
In contrast to the triggering pathway, a broadly accepted model of the amplifying
pathway has not yet emerged. A consensus exists in that the export of metabolites from the
mitochondrial matrix into the cytosol (cataplerosis) is of importance [108]. Cataplerosis is
any process by which carbon leaves the citric acid cycle in a form different from carbon
dioxide. Thereby the need for refilling the citric acid cycle (anaplerosis) is generated. So,
it can be hypothesized that a compound qualifies for the role of a nutrient secretagogue
when it increases the rate of oxidative phosphorylation and at the same time supports
cataplerosis by refilling the citric acid cycle [57].
According to this theory, glucose is insulinotropic not only because it generates NADH
and FADH2 in the matrix space but also because it refills the pool of oxaloacetate by the
action of pyruvate carboxylase. Actually, only 60% of the glucose-derived pyruvate entering
the mitochondria is metabolized by pyruvate dehydrogenase to acetyl-CoA; the other 40%
is built up to oxaloacetate. This compensates for the loss of cataplerotic metabolites and
permits the constant running of the citric acid cycle [109]. This scenario would apply when
mitochondria release glutamate, which could be generated from alpha-ketoglutarate by the
glutamate dehydrogenase reaction. Glutamate was the first in the line of candidate signal-
conveying compounds [110], also comprising alpha-ketoglutarate [111] or short-chain
acyl-CoA [112].
Some authors view the cataplerosis as part of one or more cycles of export and re-
import of metabolites to convey reducing equivalents out of the mitochondria to ultimately
increase the cytosolic levels of NADPH [113,114]. NADPH is discussed as a regulator
of exocytosis in beta cells via the deSUMOylation of SNARE proteins by SENP1 pro-
tein [115,116]. It has been shown repeatedly that glucose stimulation increases the level of
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NADPH (not to be confused with NAD(P)H, which designates the sum of both NADH
and NADPH in conventional fluorometry). But such an increase was not found for the
amplifying effect of KIC [117]. Thus, NADPH is unlikely to be an indispensable signal for
metabolic amplification. From a wider perspective, it can be postulated that candidate sig-
nalling compounds, such as monoacylglycerol [118], which can result from the metabolism
of glucose, but not of nutrient secretagogues in general, may contribute to the metabolic
amplification but are unlikely to be indispensable for this process.
As mentioned above, KIC has two different sites of entry into the citric acid cycle; in
addition to acetyl-CoA, it can generate alpha-ketoglutarate as long as the transamination
partner glutamate is available. The comparison of the metabolic amplification by KIC and
by glucose has led to an unexpected result. To obtain a metabolic situation of the beta cells,
where KIC metabolism was only minimally affected by the preceding glucose metabolism,
a 60 min nutrient-free perifusion preceded the application of exogenous nutrient. The
triggering signal was provided by blocking the KATP channels with a maximally effective
concentration of sulfonylurea. The insulinotropic effect of KIC under this condition was
about as strong as in the absence of the sulfonylurea (KIC at >5 mmol/L is a KATP channel
blocker in its own right), whereas the insulinotropic effect of glucose under the same
condition was virtually abolished and did not recover within the next hour. Or, in other
words, the metabolic amplification of glucose, but not by KIC, had been blocked by
the exposure to sulfonylurea throughout the experiment [119]. Later, it was confirmed
that the moderate depolarization by 15 mM KCl could substitute for the action of the
sulfonylurea [47].
It can thus be hypothesized that prolonged depolarization in the absence of nutrients
leads to a critically low concentration of a metabolite that cannot be replenished by glucose
alone. This view was supported by the observation that the secretion can be restarted by
adding KIV [120] or by glutamine, the effect of which could be enhanced by BCH [47].
Remarkably, the insulinotropic effect of glucose, once restarted, remained elevated after
removal of the anaplerotic starters, demonstrating that the regained rate of anaplerosis
translates into the rate of secretion (Figures 3 and 4). Taken together, the above findings
and considerations are consistent with the view that mitochondrial export of citrate and
acetoacetate, both sources of cytosolic acetyl-CoA, in insulin-secreting cells, amplifies
insulin secretion by enhancing the cytosolic supply of acetyl-CoA [120–122].
Recently, evidence on the role of cAMP as a signal-conveying compound of glucose-
stimulated insulin secretion has been presented [123], reflecting the earlier suggestion of
cAMP as the mediator of the time-dependent potentiation [124]. While the enhancing
function of receptor-mediated cAMP increase on insulin granule exocytosis is beyond
doubt [125], it is difficult to relate cAMP generation to the cataplerotic export of citrate
cycle metabolites. As a consequence, this hypothesis reduces the role of cataplerosis
in stimulus-secretion coupling to maintaining the biosynthesis of insulin in response to
nutrient stimulation. A more complete view of how nutrient-stimulated granule biogen-
esis, transport, and degradation contribute to secretion kinetics is needed to consider
this possibility.
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Figure 3. The rescue of the metabolic amplification of glucose, abolished by a period of depolarization
in the absence of nutrients. The amplification was restarted by perifusion with BCH and continued
after wash-out of BCH. The concomitant presence of glutamine and BCH resulted in a virtual jump-
start. Again, the elevated secretion level continued after wash-out of the starters. Since tolbutamide
depolarizes beta cells even in the absence of glucose, the triggering signal is continuously present.
For the underlying mechanisms, see Figure 4. Adapted from Reference [47].
Figure 4. The provision of the citric acid cycle with alpha-ketoglutarate may not only run via
transamination but also via glutamate dehydrogenase. This enzyme is allosterically activated by
leucine and by (±) BCH, a non-metabolizable leucine analog. In principle, the reaction can run in
either direction, but normally the level of endogenous glutamate is sufficient to support the generation
of alpha-ketoglutarate. The deaminating, anaplerotic reaction is further enhanced by the exogenous
offer of glutamine. The cataplerotic export of acetoacetate, which depends on sufficient levels of
succinate, is omitted for clarity. Abbreviations: BCH = 2-amino-bicyclo [2.2.1]heptane-2-carboxylic
acid, GlDH = glutamate dehydrogenase.
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9. Concluding Remarks
In this review, we have tried to outline the evolution of the ideas on how nutrient secre-
tagogues stimulate insulin secretion. The central position of the mitochondrial metabolism
in this process can be regarded as firmly established. Its specific features in the beta-cell
suggest that cataplerosis is a major contributor to nutrient-induced signaling and likely
produces the phenomenon of metabolic amplification. A broad consensus on the specific
nature of the signaling compound(s) and on its (their) mechanism(s) of action has so far
failed to emerge. For a review dealing specifically with the shortcomings of current models
of stimulus-secretion coupling, the reader is referred to [126]. Here, we have placed an
emphasis on the alternative experimental protocol and on the use of amino acids and keto
acids as experimental tools to delineate the mechanisms operative during the metabolic
amplification (for an encompassing overview, see [127]). These observations, which were
obtained with freshly isolated islets, support the view that in addition to the ATP/ADP
ratio, the second branch of signaling originates from the beta-cell mitochondria. Whatever
its precise nature, it will impact the provision of granules to the sites of exocytosis. It is con-
ceivable that multiple sites of action are involved in this process, which makes the concept
of reversible lysine acetylation by increased levels of cytosolic acetyl-CoA attractive [128].
Based on the modeling of clinical and experimental data, defective metabolic amplification
has been suggested to underlie the beta-cell dysfunction during type 2 diabetes [129].
Thus, metabolic amplification continues to be a relevant topic in diabetes research, and its
mechanisms warrant further investigation.
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36. Bränström, R.; Efendić, S.; Berggren, P.O.; Larsson, O. Direct inhibition of the pancreatic beta-cell ATP-regulated potassium
channel by alpha-ketoisocaproate. J. Biol. Chem. 1998, 273, 14113–14118. [CrossRef]
37. Heissig, H.; Urban, K.A.; Hastedt, K.; Zünkler, B.J.; Panten, U. Mechanism of the Insulin-Releasing Action of α-Ketoisocaproate
and Related α-Keto Acid Anions. Mol. Pharmacol. 2005, 68, 1097–1105. [CrossRef]
Metabolites 2021, 11, 355 13 of 16
38. Ashcroft, F.M.; Ashcroft, S.J.; Harrison, D.E. Effects of 2-ketoisocaproate on insulin release and single potassium channel activity
in dispersed rat pancreatic beta-cells. J. Physiol. 1987, 385, 517–529. [CrossRef]
39. Duchen, M.R.; Smith, P.A.; Ashcroft, F.M. Substrate-dependent changes in mitochondrial function, intracellular free calcium
con-centration and membrane channels in pancreatic beta-cells. Biochem. J. 1993, 294, 35–42. [CrossRef]
40. Smith, P.A.; Sakura, H.; Coles, B.; Gummerson, N.; Proks, P.; Ashcroft, F.M. Electrogenic arginine transport mediates stimu-lus-
secretion coupling in mouse pancreatic beta-cells. J. Physiol. 1997, 499, 625–635. [CrossRef]
41. Panten, U.; Ishida, H. Fluorescence of oxidized flavoproteins from perifused isolated pancreatic islets. Diabetologia 1975, 11,
569–573. [CrossRef]
42. Panten, U. Effects of alpha-ketomonocarboxylic acids upon insulin secretion and metabolism of isolated pancreatic islets.
Naunyn-Schmiedeberg’s Arch. Pharmacol. 1975, 291, 405–420. [CrossRef]
43. Rocheleau, J.V.; Head, W.S.; Piston, D.W. Quantitative NAD(P)H/Flavoprotein Autofluorescence Imaging Reveals Metabolic
Mechanisms of Pancreatic Islet Pyruvate Response. J. Biol. Chem. 2004, 279, 31780–31787. [CrossRef]
44. Hellerström, C. Effects of Carbohydrates on the Oxygen Consumption of Isolated Pancreatic Islets of Mice. Endocrinology 1967, 81,
105–112. [CrossRef]
45. Panten, U.; Klein, H. O2Consumption by Isolated Pancreatic Islets, as Measured in a Microincubation System with a Clark-Type
Electrode*. Endocrinology 1982, 111, 1595–1600. [CrossRef]
46. Doliba, N.M.; Wehrli, S.L.; Vatamaniuk, M.Z.; Qin, W.; Buettger, C.W.; Collins, H.W.; Matschinsky, F.M. Metabolic and ionic
coupling factors in amino acid-stimulated insulin release in pancreatic beta-HC9 cells. Am. J. Physiol. Endocrinol. Metab. 2007, 292,
E1507–E1519. [CrossRef]
47. Schulze, T.; Morsi, M.; Reckers, K.; Brüning, D.; Seemann, N.; Panten, U.; Rustenbeck, I. Metabolic amplification of insulin
secretion is differentially desensitized by depolarization in the absence of exogenous fuels. Metabolism 2017, 67, 1–13. [CrossRef]
48. Bergsten, P.; Westerlund, J.; Liss, P.; Carlsson, P.-O. Primary in vivo oscillations of metabolism in the pancreas. Diabetes 2002, 51,
699–703. [CrossRef]
49. Dean, P.M. Ultrastructural morphometry of the pancreatic beta-cell. Diabetologia 1973, 9, 115–119. [CrossRef]
50. Bonner-Weir, S.; Orci, L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982, 31,
883–889. [CrossRef]
51. Nyman, L.R.; Ford, E.; Powers, A.C.; Piston, D.W. Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo.
Am. J. Physiol. Metab. 2010, 298, E807–E814. [CrossRef]
52. Denton, R.M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta. 2009, 1787, 1309–1316.
[CrossRef]
53. Gilbert, M.; Jung, S.R.; Reed, B.J.; Sweet, I.R. Islet oxygen consumption and insulin secretion tightly coupled to calcium derived
from L-type calcium channels but not from the endoplasmic reticulum. J. Biol. Chem. 2008, 283, 24334–24342. [CrossRef]
54. Schuit, F.; De Vos, A.; Farfari, S.; Moens, K.; Pipeleers, D.; Brun, T.; Prentki, M. Metabolic Fate of Glucose in Purified Islet Cells. J.
Biol. Chem. 1997, 272, 18572–18579. [CrossRef] [PubMed]
55. Tamarit-Rodriguez, J.; Idahl, L.A.; Giné, E.; Alcazar, O.; Sehlin, J. Lactate production in pancreatic islets. Diabetes 1998, 47,
1219–1223. [CrossRef] [PubMed]
56. Sekine, N.; Cirulli, V.; Regazzi, R.; Brown, L.J.; Gine, E.; Tamarit-Rodriguez, J.; Girotti, M.; Marie, S.; MacDonald, M.J.; Wollheim,
C.B.; et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells.
Potential role in nutrient sensing. J. Biol. Chem. 1994, 269, 4895–4902. [CrossRef]
57. Jitrapakdee, S.; Wutthisathapornchai, A.; Wallace, J.C.; Macdonald, M.J. Regulation of insulin secretion: Role of mitochondrial
signalling. Diabetologia 2010, 53, 1019–1032. [CrossRef]
58. Fex, M.; Nicholas, L.M.; Vishnu, N.; Medina, A.; Sharoyko, V.V.; Nicholls, D.G.; Spégel, P.; Mulder, H. The pathogenetic role of
β-cell mitochondria in type 2 diabetes. J. Endocrinol. 2018, 236, R145–R159. [CrossRef]
59. Dean, P.M.; Matthews, E.K. Electrical activity in pancreatic islet cells. Nature 1968, 219, 389–390. [CrossRef]
60. Meissner, H.P. Electrical characteristics of the beta-cells in pancreatic islets. J. Physiol. 1976, 72, 757–767.
61. Henquin, J.C. D-Glucose inhibits potassium efflux from pancreatic islet cells. Nat. Cell Biol. 1978, 271, 271–273. [CrossRef]
62. Ashcroft, S.J.H.; Weerasinghe, L.C.C.; Randle, P.J. Interrelationship of islet metabolism, adenosine triphosphate content and
insulin release. Biochem. J. 1973, 132, 223–231. [CrossRef]
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